Robotic Urologic Surgery: A Technical Masterclass Webcast (2018): Kidney & Bladder

Robotic Urologic Surgery: A Technical Masterclass provides a structured approach to advanced robotic surgery for conditions of the prostate, kidney, and bladder with an emphasis on radical prostatectomy and partial nephrectomy. This course will also focus on emerging technologies including genomic testing and advanced imaging. Experienced world-class faculty with more than a decade of experience with complex robotic surgery will provide you with instruction to refine your technique and achieve superior results.

The first day will focus on prostate surgery. Specific surgical techniques will be presented in a step-by-step operative outline. Includes issues such as optimizing outcomes of robotic radical prostatectomy, discussing complications, and tips and tricks of challenging cases. High Definition live transmission of robotic radical prostatectomy by Dr. Vipul Patel will include recent modifications in technique. The second day will be devoted to kidney surgery and bladder surgery. The course will include multiple video segments demonstrating tips and tricks, management of anatomic anomalies and challenging situations, with expert faculty to provide commentary and discussion. Audience participation will be encouraged to ensure one on one interaction. Panel discussions with expert faculty will address methods to recognize and address complications and problems for each of the surgical procedures.

    ACKNOWLEDGEMENTS

    This educational series is supported by independent educational grants from:

    • CONMED
    • Cooper Surgical
    • GenomeDx Biosciences
    • Intuitive Surgical, Inc.
    • Teleflex

    Target Audience

    • Urologists

    Learning Objectives

    At the conclusion of this course, participants will be able to:

    1. Examine and analyze the surgical techniques and methodology behind complex robotic urologic cancer surgeries such as prostatectomy, cystectomy and partial nephrectomy.
    2. Assess the key complications and outline the intra-operative and post-operative management related to robotic surgery procedures using video-based learning, surgical video and live surgery and expert panel discussion.
    3. Demonstrate current and upcoming protocols for regaining potency and continence following robotic prostatectomy and cystectomy.
    4. Provide a clinical update on treating, diagnosing, and managing complications of localized, regionally advanced, and metastatic urinary cancer.
    5. Provide a clinical update on emerging technologies in prostate cancer including MRI Fusion Biopsy, single port surgery, and genomic testing.
    6. Apply the surgical techniques and methodology behind complex robotic cancer surgeries including partial nephrectomy, robotic prostatectomy, and nephroureterectomy.
    Course summary
    Available credit: 
    • 0.00 AMA PRA Category 1 Credit™
    • 0.00 Non-Physician Participation
    Course opens: 
    11/08/2018
    Course expires: 
    12/11/2021
    Rating: 
    0

    DAY ONE: PROSTATE

    SESSION I: SCREENING AND DIAGNOSIS OF PROSTATE CANCER
                      MODERATOR: PETER R. CARROLL, MD, MPH
                      PANEL: MATTHEW R. COOPERBERG, MD, MPH, FACS; SAMIR S. TANEJA, MD

    • State of the Art Lecture: Prostate Cancer Screening – Where Do We Stand? - Peter R. Carroll, MD, MPH
    • Risk Stratifying Patients with Elevated PSAs: Current and Future Trends - Matthew R. Cooperberg, MD, MPH, FACS
    • Use of 3T mp MRI in Evaluating the Possibility of Prostate Cancer - Samir S. Taneja, MD
    • Optimizing MRI Fusion Prostate Biopsy: Utility and Technique - Samir S. Taneja, MD
    • Q&A with Moderator and Panel

    SESSION II: EVALUATION OF THE NEWLY DIAGNOSED PROSTATE CANCER PATIENT
                       MODERATOR: JOHN W. DAVIS, MD
                       PANEL: PETER R. CARROLL, MD, MPH; MATTHEW R. COOPERBERG, MD, MPH, FACS

    • The Use of Genomic Testing in Newly Diagnosed Low and Intermediate Risk Prostate Cancer - Matthew R. Cooperberg, MD, MPH, FACS
    • Active Surveillance Guidelines: Initial and Long Term Management - John W. Davis, MD
    • Low and Intermediate Risk Prostate Cancer: Who Benefits from Surgery? - Peter R. Carroll, MD, MPH
    • Prostate Cancer Trends Over the Last Decade: Is the Disease Becoming More Advanced? - Peter R. Carroll, MD, MPH
    • Q&A with Moderator and Panel

    SESSION III: LIVE SURGERY - NERVE SPARING RADICAL PROSTATECTOMY

    Surgeon: Vipul Patel, MD
    OR Moderator: Peter R. Carroll, MD, MPH
    Auditorium Moderator: Raju Thomas, MD, FACS, FRCS, MHA
    Panel: John W. Davis, MD; Raj S. Pruthi, MD, MHA, FACS; Bernardo Rocco, MD; Samir S. Taneja, MD

    SESSION IV: PROSTATE CANCER SURGERY
                        MODERATOR: JOHN W. DAVIS, MD
                        PANEL: PETER R. CARROLL, MD, MPH; RAFAEL FERREIRA COELHO, MD; BERNARDO ROCCO, MD

    • The Prostate Cancer Consult: What Patients Need to Know Before Making a Decision - John W. Davis, MD
    • Improving Operating Room Efficiency and Team Training - John W. Davis, MD

    TECHNICAL INNOVATIONS TO OPTIMIZE OUTCOMES

    • Overview of RALP Technique: Key Steps That Actually Make a Difference - Raju Thomas, MD, FACS, FRCS, MHA
    • Techniques to Improve Urinary Continence Outcomes - Bernardo Rocco, MD
    • Techniques to Reduce Positive Margins but Maximize Nerve Sparing - Peter R. Carroll, MD, MPH
    • 10,000 RALPs Later: Lessons Learned - Vipul Patel, MD
    • Understanding the NVB and the Technique of Nerve Sparing - Vipul Patel, MD
    • Planning the Level of Nerve Sparing and Determining the Amount of ECE During RALP - Bernardo Rocco, MD
    • Q&A with Moderator and Panel

    SESSION V: HIGH RISK PROSTATE CANCER SURGERY
                       MODERATOR: RAJU THOMAS, MD, FACS, FRCS, MHA
                       PANEL: PETER R. CARROLL, MD, MPH; JOHN W. DAVIS, MD; BERNARDO ROCCO, MD

    • Surgery for Non‐Organ Confined Prostate Cancer: Technical Considerations - John W. Davis, MD
    • Extended Lymph Node Dissection - Bernardo Rocco, MD
    • Salvage RALP: Indications, Techniques and Outcomes - Vipul Patel, MD
    • Salvage Lymph Node Dissection for Rising PSA Post Treatment - Rafael Ferreira Coelho, MD
    • Surgery for Oligometastatic Disease: Indications and Outcomes - Rafael Ferreira Coelho, MD

    SESSION VI: VIDEO SESSION
                        MODERATOR: VIPUL PATEL, MD
                        PANEL: RAFAEL FERREIRA COELHO, MD; MATTHEW R. COOPERBERG, MD, MPH, FACS; JOHN W. DAVIS, MD; BERNARDO ROCCO, MD; RAJU THOMAS, MD, FACS, FRCS, MHA

    • Complications of RALP - Rafael Ferreira Coelho, MD
    • Extreme Robotic Surgery: Cases that Made the Experts Sweat - Vipul Patel, MD
    • Video: Simple Prostatectomy and Bladder Diverticulectomy - Raju Thomas, MD, FACS, FRCS, MHA
    • Q&A with Moderator and Panel

    SESSION VII: ADVANCED PROSTATE CANCER

    • The Increased Utility of Surgery for Advanced Prostate Cancer: Who Benefits? - Peter R. Carroll, MD, MPH
    • Post Prostatectomy Genomic Tests: Indications and Utility - Matthew R. Cooperberg, MD, MPH, FACS
    • Use of Advanced Imaging and New Biomarkers to Evaluate PSA Recurrence - Rafael Ferreira Coelho, MD
    • Medical Therapy for Metastatic and Hormone Resistant Prostate Cancer: What a Urologist Needs to Know - John W. Davis, MD

    SESSION VIII: NEW INNOVATIONS
                          MODERATOR: CHANDRU P. SUNDARAM, MD

    • New Robotic Platforms and Technologies on the Horizon - Vipul Patel, MD
    • Audience Q&A Session

     

    DAY TWO: KIDNEY & BLADDER

    SESSION I: RENAL TUMORS
                      MODERATOR: CHANDRU P. SUNDARAM, MD
                      PANEL: SAM B. BHAYANI, MD, MS; RAFAEL FERREIRA COELHO, MD; JAMES R. PORTER, MD; RAJU THOMAS, MD, FACS, FRCS, MHA

    • State of the Art Lecture: Introduction to Robotic Renal Surgery - Chandru P. Sundaram, MD
    • Live Kidney Surgery: Robotic Partial Nephrectomy

    Surgeon: Prof. Alexandre Mottrie, MD, PhD
    Moderator: Sam B. Bhayani, MD, MS
    Panel: Rafael Ferreira Coelho, MD; James R. Porter, MD; Chandru P. Sundaram, MD; Raju Thomas, MD, FACS, FRCS, MHA

    SESSION II: RENAL MASS MANAGEMENT
                      MODERATOR: RAJU THOMAS, MD, FACS, FRCS, MHA
                      PANEL: JAMES R. PORTER, MD; CHANDRU P. SUNDARAM, MD

    • Evaluation of a Renal Mass: Nephrometry Scoring and Case Selection - Raju Thomas, MD, FACS, FRCS, MHA
    • Role of Renal Biopsy and Active Surveillance of Small Renal Masses - Raju Thomas, MD, FACS, FRCS, MHA
    • Renal Ischemia Management - Chandru P. Sundaram, MD
    • Patient Positioning and Port Placement and Preparing the Team for an Emergency Situation - Sam B. Bhayani, MD, MS
    • Q&A with Moderator and Panel

    SESSION III: KIDNEY VIDEO SESSION
                        MODERATOR: SAM B. BHAYANI, MD, MS
                        PANEL: JAMES R. PORTER, MD; CHANDRU P. SUNDARAM, MD; RAJU THOMAS, MD, FACS, FRCS, MHA

    • Robotic Pyeloplasty and Pyelolithotomy - Raju Thomas, MD, FACS, FRCS, MHA
    • Robotic Ureteral Reimplantation - Raju Thomas, MD, FACS, FRCS, MHA
    • Robotic Radical Nephrectomy and Nephroureterectomy - Chandru P. Sundaram, MD

    VIDEOS: ROBOTIC PARTIAL NEPHRECTOMY TIPS AND TRICKS

    • Step By Step Approach to Partial Nephrectomy: Key Steps - Sam B. Bhayani, MD, MS
    • Video Transperitoneal Approach: Tumor Excision and Renorraphy - Sam B. Bhayani, MD, MS
    • Video Retroperitoneal Approach: Tumor Excision and Renorraphy - James R. Porter, MD
    • Video Complex Cystic Mass - James R. Porter, MD
    • Video Hilar Tumor - Chandru P. Sundaram, MD
    • Video Large Renal Mass - Chandru P. Sundaram, MD
    • When to Use Firefly: Selective or Early Unclamping of the Renal Artery - Sam B. Bhayani, MD, MS
    • Q&A with Moderator and Panel
    • Case Presentation: Management of Positive Margins, Intraoperative Frozen Sections, and Tumor Spillage -  Raju Thomas, MD, FACS, FRCS, MHA
    • Case Presentations: Preoperataive Decision Making - Chandru P. Sundaram, MD
    • Case Discussion Q&A with Panel

    SESSION IV: ADVANCED ROBOTIC RENAL SURGERY 
                       MODERATOR: RAJU THOMAS, MD, FACS, FRCS, MHA
                       PANEL: RAFAEL FERREIRA COELHO, MD; BERNARDO ROCCO, MD; RAJU THOMAS, MD, FACS, FRCS, MHA

    • Video: Complications of Renal Surgery Management - Sam B. Bhayani, MD, MS
    • Video: Challenging Cases

                                            James R. Porter, MD
                                            •    IVC and Renal Vein Thrombectomy and Nephrectomy
                                            •    Difficult Renal Tumors

                                             Chandru P. Sundaram, MD
                                            •    Intraoperative Troubleshooting

    • Robotic Renal Transplantation - Bernardo Rocco, MD
    • Robotic RPLND - Raju Thomas, MD, FACS, FRCS, MHA
    • Robotic Node Dissection for Penile Cancer - Rafael Ferreira Coelho, MD
    • Q&A with Moderator and Panel

    SESSION V: BLADDER CANCER
                       MODERATOR: RAJ S. PRUTHI, MD, MHA, FACS
                       PANEL: RAFAEL FERREIRA COELHO, MD; BERNARDO ROCCO, MD; RAJU THOMAS, MD, FACS, FRCS, MHA

    • State of the Art Lecture: Outcomes of Radical Robotic Cystectomy - Raj S. Pruthi, MD, MHA, FACS
    • Video: Technique for Radical Cystectomy and Urinary Diversion - Raj S. Pruthi, MD, MHA, FACS
    • Robotic Ileal Conduit  - Rafael Ferreira Coelho, MD
    • Robotic Intracororeal Urinary Diversion- Bernardo Rocco, MD
    • Audience Q&A Session

    Faculty Disclosures

    Faculty Disclosures

    Education Council Disclosures

    Education Council Disclosures

    Method Of Participation: 

    Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

    Estimated time to complete this activity: 18.75

    Release Date: December, 2018
    Expiration Date: December, 2021

    Accreditation: 

    The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation: 

    The American Urological Association designates this enduring activity for a maximum of 18.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Other Learners: 

    The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

    Evidence Based Content: 

    It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

    AUA Disclosure Policy: 

    All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to
    provide learners information with which they can make their own judgments.

    Resolution of Identified Conflict of Interest: 

    All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

    • Peer review for valid, evidence‐based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Work Group or its subgroup.
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point‐counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty

    Off‐label or Unapproved Use of Drugs or Devices:

     The audience is advised that this continuing medical education activity may contain reference(s) to off‐label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

    Available Credit

    • 0.00 AMA PRA Category 1 Credit™
    • 0.00 Non-Physician Participation

    Accreditation Period

    Course opens: 
    11/08/2018
    Course expires: 
    12/11/2021
    Please login or register to take this course.